351 related articles for article (PubMed ID: 32850862)
41. Activation of LINE-1 Retrotransposon Increases the Risk of Epithelial-Mesenchymal Transition and Metastasis in Epithelial Cancer.
Rangasamy D; Lenka N; Ohms S; Dahlstrom JE; Blackburn AC; Board PG
Curr Mol Med; 2015; 15(7):588-97. PubMed ID: 26321759
[TBL] [Abstract][Full Text] [Related]
42. Metabolic Plasticity and Epithelial-Mesenchymal Transition.
Thomson TM; Balcells C; Cascante M
J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31277295
[TBL] [Abstract][Full Text] [Related]
43. Global and gene specific DNA methylation in breast cancer cells was not affected during epithelial-to-mesenchymal transition in vitro.
Smolkova B; Miklikova S; Kajabova VH; Babelova A; Yamani NE; Zduriencikova M; Fridrichova I; Zmetakova I; Krivulcik T; Kalinkova L; Matuskova M; Kucerova L; Dusinska M
Neoplasma; 2016; 63(6):901-910. PubMed ID: 27565328
[TBL] [Abstract][Full Text] [Related]
44. Epithelial-to-Mesenchymal Transition: Epigenetic Reprogramming Driving Cellular Plasticity.
Skrypek N; Goossens S; De Smedt E; Vandamme N; Berx G
Trends Genet; 2017 Dec; 33(12):943-959. PubMed ID: 28919019
[TBL] [Abstract][Full Text] [Related]
45. Role of cellular reprogramming and epigenetic dysregulation in acquired chemoresistance in breast cancer.
Ponnusamy L; Mahalingaiah PKS; Chang YW; Singh KP
Cancer Drug Resist; 2019; 2(2):297-312. PubMed ID: 35582717
[TBL] [Abstract][Full Text] [Related]
46. Klf4 reduces stemness phenotype, triggers mesenchymal-epithelial transition (MET)-like molecular changes, and prevents tumor progression in nasopharygeal carcinoma.
Li X; Zhao Z; Zhang X; Yang S; Lin X; Yang X; Lin X; Shi J; Wang S; Zhao W; Li J; Gao F; Liu M; Ma N; Luo W; Yao K; Sun Y; Xiao S; Xiao D; Jia J
Oncotarget; 2017 Nov; 8(55):93924-93941. PubMed ID: 29212199
[TBL] [Abstract][Full Text] [Related]
47. Metabolic re-wiring of isogenic breast epithelial cell lines following epithelial to mesenchymal transition.
Halldorsson S; Rohatgi N; Magnusdottir M; Choudhary KS; Gudjonsson T; Knutsen E; Barkovskaya A; Hilmarsdottir B; Perander M; Mælandsmo GM; Gudmundsson S; Rolfsson Ó
Cancer Lett; 2017 Jun; 396():117-129. PubMed ID: 28323032
[TBL] [Abstract][Full Text] [Related]
48. Targeting cellular memory to reprogram the epigenome, restore potential, and improve somatic cell nuclear transfer.
Eilertsen KJ; Power RA; Harkins LL; Misica P
Anim Reprod Sci; 2007 Mar; 98(1-2):129-46. PubMed ID: 17166676
[TBL] [Abstract][Full Text] [Related]
49. The epithelial to mesenchymal transition in pancreatic cancer: A systematic review.
Beuran M; Negoi I; Paun S; Ion AD; Bleotu C; Negoi RI; Hostiuc S
Pancreatology; 2015; 15(3):217-25. PubMed ID: 25794655
[TBL] [Abstract][Full Text] [Related]
50. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control.
Grassi ML; Palma CS; Thomé CH; Lanfredi GP; Poersch A; Faça VM
J Proteomics; 2017 Jan; 151():2-11. PubMed ID: 27394697
[TBL] [Abstract][Full Text] [Related]
51. TGF-β signaling and epithelial-mesenchymal transition in cancer progression.
Katsuno Y; Lamouille S; Derynck R
Curr Opin Oncol; 2013 Jan; 25(1):76-84. PubMed ID: 23197193
[TBL] [Abstract][Full Text] [Related]
52. Lysine-specific histone demethylase 1 inhibition promotes reprogramming by facilitating the expression of exogenous transcriptional factors and metabolic switch.
Sun H; Liang L; Li Y; Feng C; Li L; Zhang Y; He S; Pei D; Guo Y; Zheng H
Sci Rep; 2016 Aug; 6():30903. PubMed ID: 27481483
[TBL] [Abstract][Full Text] [Related]
53. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
[TBL] [Abstract][Full Text] [Related]
54. Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma.
Jayachandran A; Dhungel B; Steel JC
J Hematol Oncol; 2016 Aug; 9(1):74. PubMed ID: 27578206
[TBL] [Abstract][Full Text] [Related]
55. Genome-wide gene expression analyses reveal unique cellular characteristics related to the amenability of HPC/HSCs into high-quality induced pluripotent stem cells.
Gao S; Tao L; Hou X; Xu Z; Liu W; Zhao K; Guo M; Wang H; Cai T; Tian J; Gao S; Chang G
Stem Cell Res Ther; 2016 Mar; 7():40. PubMed ID: 26979597
[TBL] [Abstract][Full Text] [Related]
56. Involvement of partial EMT in cancer progression.
Saitoh M
J Biochem; 2018 Oct; 164(4):257-264. PubMed ID: 29726955
[TBL] [Abstract][Full Text] [Related]
57. EMT-induced metabolite signature identifies poor clinical outcome.
Bhowmik SK; Ramirez-Peña E; Arnold JM; Putluri V; Sphyris N; Michailidis G; Putluri N; Ambs S; Sreekumar A; Mani SA
Oncotarget; 2015 Dec; 6(40):42651-60. PubMed ID: 26315396
[TBL] [Abstract][Full Text] [Related]
58. Aberrant DNA methylation reprogramming during induced pluripotent stem cell generation is dependent on the choice of reprogramming factors.
Planello AC; Ji J; Sharma V; Singhania R; Mbabaali F; Müller F; Alfaro JA; Bock C; De Carvalho DD; Batada NN
Cell Regen; 2014; 3(1):4. PubMed ID: 25408883
[TBL] [Abstract][Full Text] [Related]
59. Metabolic reprogramming in breast cancer results in distinct mitochondrial bioenergetics between luminal and basal subtypes.
Lunetti P; Di Giacomo M; Vergara D; De Domenico S; Maffia M; Zara V; Capobianco L; Ferramosca A
FEBS J; 2019 Feb; 286(4):688-709. PubMed ID: 30657636
[TBL] [Abstract][Full Text] [Related]
60. EMT and MET as paradigms for cell fate switching.
Chen J; Han Q; Pei D
J Mol Cell Biol; 2012 Apr; 4(2):66-9. PubMed ID: 22140271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
